| Fhp Home Health 548 South Marine Corps Drive, Tamuning, GU, 96913 | |
| (671) 646-4933 |
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| Name | Fhp Home Health |
|---|---|
| Location | 548 South Marine Corps Drive, Tamuning, Guam |
| Hospice ID | 651501 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 010 |
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| NPI Number | 1497859565 |
| Organization Name | Takecare Insurance Company Inc |
| Address | 415 Chalan San Antonio Tamuning, Guam, 96913 |
| Phone Number | (671)646-4933 |
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| NPI Number | 1700979713 |
| Organization Name | Takecare Insurance Company Inc |
| Address | 415 Chalan San Antonio Tamuning, Guam, 96913 |
| Phone Number | (671)646-4933 |
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| Home Health Aides | 2 |
| Licensed Practical or Vocational Nurses | 3 |
| Physicians | 2 |
| Registered Nurses | 10 |
| Other Personnel | 3 |
| Total Employees | 20 |
|---|
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| Counselors | 1 |
| Homemakers | 4 |
| Registered Nurses | 2 |
| Total Volunteers | 7 |
|---|
News Archive
iPierian, Inc., the leading company focused on creating new therapeutics discovered using cellular reprogramming and directed differentiation of patient cells, today announced that it has been awarded a three-year $1.5 million "Basic Biology Award" from the California Institute of Regenerative Medicine.
Today's headlines include reports about the Senate's vote to reject an effort to expand exemptions to the Obama administration's birth control coverage rule.
With the cost of putting a single new drug on the pharmacy shelves topping a staggering $1 billion, scientists are reporting development of a way to determine if an already-approved drug might be used to treat a different disease. The technique for repurposing existing medicines could cut drug development costs and make new medicine available to patients faster, they report in ACS' Journal of Medicinal Chemistry.
University of North Carolina at Chapel Hill researchers have made a discovery that may have implications for the treatment of liver-based genetic defects such as hemophilia A and B in humans.
› Verified 8 days ago
| Health Services Of The Pacific - Hospice Location: 809 Chalan Pasaheru, Unit 2, Tamuning, Guam, 96913 Phone: (671) 646-4933 |
| Fhp Home Health Location: 548 South Marine Corps Drive, Tamuning, Guam, 96913 Phone: (671) 646-4933 |